| | | | | |

Mesothelioma-Related Lung Fluid: Better Diagnosis with HIgh Tech Tool

25111026_patient7Technology that integrates 18-FDG PET and CT imaging together may be a more powerful way to diagnose malignant lung fluid in people with pleural mesothelioma than either modality alone.

Scientists in China did a retrospective study to compare the imaging results of people with pleural effusion from various causes, including malignant pleural mesothelioma. 

The team found that the integrated PET/CT technology accurately diagnosed malignant pleural effusion better than 18FDG-PET imaging alone and much better than CT imaging.

What is Malignant Pleural Effusion?

Malignant pleural effusion is a condition where fluid containing cancer cells collects in the pleural space between the lungs and the chest wall. If this fluid is caused by a condition other than malignant mesothelioma or another cancer, it can be benign, meaning it does not contain cancer cells.

Recognizing whether this fluid is malignant or benign is an important part of pinpointing the underlying condition that is causing it and making plans for treatment. As many as 90 percent of pleural mesothelioma patients experience malignant pleural effusion, which can cause chest pain, shortness of breath, and fatigue.

Distinguishing Benign from Malignant Effusion

Identifying when pleural effusion is malignant can be an important step toward making a diagnosis of malignant mesothelioma or another type of cancer. Several cancers, including ovarian, breast, and lung cancer, tend to cause pleural effusion when they metastasize or spread.

The new study conducted at Harbin Medical University found that integrated 18-FDG PET/CT accurately detected malignant pleural effusion in 93.5% of cases, while CT studies alone had a sensitivity of just 75%. 18-FDG PET alone returned an accurate positive result in 91.7% of cases.

“18-FDG PET/CT integrated imaging is a more reliable modality in distinguishing malignant from benign pleural effusion than 18-FDG PET imaging and CT imaging alone,” writes lead author Yajuan Sun in the online open journal PLoS One.

Mesothelioma patients and others with malignant pleural effusion were found to have nodules or irregular pleural thickening on CT imaging and a higher uptake of the 18-FDG tracer on PET imaging.

Because malignant mesothelioma is so rare, the technology and expertise needed to accurately identify and treat it is not always readily accessible. For the best mesothelioma outcomes, mesothelioma patients and their families are urged to look for care centers that have the most experience dealing with asbestos cancer.

Source:

Sun, Y, et al, “The Role of 18-F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion”, August 25, 2016, PLoS One

Similar Posts

  • | |

    Mesothelioma survivor Paul Kraus, alive and well 19 years after writing “Surviving Mesothelioma and Other Cancers

    Paul Kraus is considered the longest documented mesothelioma survivor in the world. He was diagnosed in 1997 with mesothelioma so widespread that he was given little hope of survival. Not willing to give up, he worked with a team of doctors to create his own tailored treatment protocol. This protocol included dramatic life style change, experimental therapies, dietary changes, mind-body medicine, and other modalities. Paul was fortunate. The protocol he and his doctors created helped him keep the mesothelioma in check. His book “Surviving Mesothelioma and Other Cancers: A Patient’s Guide” details his cancer voyage, the decisions he made, and his philosophies about health and healing. This book is now the best-selling mesothelioma book in the world and has inspired…

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…